{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:42:25Z","timestamp":1793734945366,"version":"4.6.1"},"reference-count":201,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41581-026-01085-x","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T08:02:40Z","timestamp":1779436960000},"page":"622-634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The pathophysiology of pre-eclampsia"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5975-2843","authenticated-orcid":false,"given":"Annemarie","family":"Hennessy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2418-9458","authenticated-orcid":false,"given":"Jolene","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Makris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"1085_CR1","unstructured":"World Health Organization. Maternal mortality. WHO https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/maternal-mortality (2025)."},{"key":"1085_CR2","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1552-6909.2010.01172.x","volume":"39","author":"MJ Bell","year":"2010","unstructured":"Bell, M. J. A historical overview of preeclampsia-eclampsia. J. Obstet. Gynecol. Neonatal Nurs. 39, 510\u2013518 (2010).","journal-title":"J. Obstet. Gynecol. Neonatal Nurs."},{"key":"1085_CR3","doi-asserted-by":"publisher","first-page":"S819","DOI":"10.1016\/j.ajog.2020.08.108","volume":"226","author":"M Fishel Bartal","year":"2022","unstructured":"Fishel Bartal, M., Lindheimer, M. D. & Sibai, B. M. Proteinuria during pregnancy: definition, pathophysiology, methodology, and clinical significance. Am. J. Obstet. Gynecol. 226, S819\u2013S834 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1085_CR4","doi-asserted-by":"publisher","first-page":"S895","DOI":"10.1016\/j.ajog.2020.09.026","volume":"226","author":"AC Staff","year":"2022","unstructured":"Staff, A. C. et al. Failure of physiological transformation and spiral artery atherosis: their roles in pre-eclampsia. Am. J. Obstet. Gynecol. 226, S895\u2013S906 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1085_CR5","doi-asserted-by":"publisher","first-page":"S745","DOI":"10.1016\/j.ajog.2017.11.577","volume":"218","author":"GJ Burton","year":"2018","unstructured":"Burton, G. J. & Jauniaux, E. Pathophysiology of placental-derived fetal growth restriction. Am. J. Obstet. Gynecol. 218, S745\u2013S761 (2018).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1085_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","volume":"27","author":"LA Magee","year":"2022","unstructured":"Magee, L. A. et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 27, 148\u2013169 (2022).","journal-title":"Pregnancy Hypertens."},{"key":"1085_CR7","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","volume":"359","author":"D Altman","year":"2002","unstructured":"Altman, D. et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie trial: a randomised placebo-controlled trial. Lancet 359, 1877\u20131890 (2002).","journal-title":"Lancet"},{"key":"1085_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081959","volume":"8","author":"JF von Schmidt auf Altenstadt","year":"2013","unstructured":"von Schmidt auf Altenstadt, J. F., Hukkelhoven, C. W., van Roosmalen, J. & Bloemenkamp, K. W. Pre-eclampsia increases the risk of postpartum haemorrhage: a nationwide cohort study in the Netherlands. PLoS ONE 8, e81959 (2013).","journal-title":"PLoS ONE"},{"key":"1085_CR9","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.13.07003","volume":"14","author":"S Khan","year":"2023","unstructured":"Khan, S. et al. Pre-eclampsia and eclampsia-specific maternal mortality in Bangladesh: levels, trends, timing, and care-seeking practices. J. Glob. Health. 14, 07003 (2023).","journal-title":"J. Glob. Health."},{"key":"1085_CR10","volume":"10","author":"D Churchill","year":"2018","unstructured":"Churchill, D. et al. Interventionist versus expectant care for severe pre-eclampsia between 24 and 34\u2009weeks\u2019 gestation. Cochrane Database Syst. Rev. 10, CD003106 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1085_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10020325","volume":"10","author":"A Awaludin","year":"2022","unstructured":"Awaludin, A., Rahayu, C., Daud, N. A. A. & Zakiyah, N. Antihypertensive medications for severe hypertension in pregnancy: a systematic review and meta-analysis. Healthcare 10, 325 (2022).","journal-title":"Healthcare"},{"key":"1085_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/JBM.S273047","volume":"13","author":"O Erez","year":"2022","unstructured":"Erez, O. et al. DIC in pregnancy \u2014 pathophysiology, clinical characteristics, diagnostic scores, and treatments. J. Blood Med. 13, 21\u201344 (2022).","journal-title":"J. Blood Med."},{"key":"1085_CR13","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1056\/NEJMoa1602044","volume":"375","author":"AT Tita","year":"2016","unstructured":"Tita, A. T. et al. Adjunctive azithromycin prophylaxis for cesarean delivery. N. Engl. J. Med. 375, 1231\u20131241 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1085_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.43804","volume":"6","author":"E Havers-Borgersen","year":"2023","unstructured":"Havers-Borgersen, E. et al. Pre-eclampsia and long-term risk of venous thromboembolism. JAMA Netw. Open 6, e2343804 (2023).","journal-title":"JAMA Netw. Open"},{"key":"1085_CR15","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMoa1704559","volume":"377","author":"DL Rolnik","year":"2017","unstructured":"Rolnik, D. L. et al. Aspirin versus placebo in pregnancies at high risk for preterm pre-eclampsia. N. Engl. J. Med. 377, 613\u2013622 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1085_CR16","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","volume":"369","author":"LM Askie","year":"2007","unstructured":"Askie, L. M., Duley, L., Henderson-Smart, D. J. & Stewart, L. A. & PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369, 1791\u20131798 (2007).","journal-title":"Lancet"},{"key":"1085_CR17","unstructured":"World Bank Group. Maternal mortality ratio (modeled estimate, per 100,000 live births). https:\/\/data.worldbank.org\/indicator\/SH.STA.MMRT?most_recent_value_desc=false (2023)."},{"key":"1085_CR18","unstructured":"World Heath Organization Global Health Observatory. SDG Target 3.2: end preventable deaths of newborns and children under 5 years of age. https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/sdg-target-3_2-newborn-and-child-mortality (2023)."},{"key":"1085_CR19","unstructured":"World Health Organization Regional Office for Africa, Integrated African Health Observatory. Maternal mortality: the urgency of a systemic and multisectoral approach in mitigating maternal deaths in Africa. https:\/\/files.aho.afro.who.int\/afahobckpcontainer\/production\/files\/iAHO_Maternal_Mortality_Regional_Factsheet.pdf (2023)."},{"key":"1085_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-13-12","volume":"13","author":"A Gordon","year":"2013","unstructured":"Gordon, A., Raynes-Greenow, C., McGeechan, K., Morris, J. & Jeffery, H. Risk factors for antepartum stillbirth and the influence of maternal age in New South Wales Australia: a population based study. BMC Pregnancy Childbirth 13, 12 (2013).","journal-title":"BMC Pregnancy Childbirth"},{"key":"1085_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1600-0412.2010.01030.x","volume":"90","author":"M Tikkanen","year":"2011","unstructured":"Tikkanen, M. Placental abruption: epidemiology, risk factors and consequences. Acta. Obstet. Gynecol. Scand. 90, 140\u2013149 (2011).","journal-title":"Acta. Obstet. Gynecol. Scand."},{"key":"1085_CR22","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1161\/CIRCULATIONAHA.113.003904","volume":"129","author":"EW Seely","year":"2014","unstructured":"Seely, E. W. & Ecker, J. Chronic hypertension in pregnancy. Circulation 129, 1254\u201361 (2014).","journal-title":"Circulation"},{"key":"1085_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.preghy.2021.12.013","volume":"27","author":"MC Myers","year":"2022","unstructured":"Myers, M. C. et al. Effect of positioning on blood pressure measurement in pregnancy. Pregnancy Hypertens. 27, 110\u2013114 (2022).","journal-title":"Pregnancy Hypertens."},{"key":"1085_CR24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/HJH.0000000000001848","volume":"37","author":"MR Salazar","year":"2019","unstructured":"Salazar, M. R. et al. Nocturnal hypertension in high-risk mid-pregnancies predict the development of pre-eclampsia\/eclampsia. J. Hypertens. 37, 182\u2013186 (2019).","journal-title":"J. Hypertens."},{"key":"1085_CR25","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nrcardio.2011.115","volume":"8","author":"G Mancia","year":"2011","unstructured":"Mancia, G., Bombelli, M., Seravalle, G. & Grassi, G. Diagnosis and management of patients with white-coat and masked hypertension. Nat. Rev. Cardiol. 8, 686\u2013693 (2011).","journal-title":"Nat. Rev. Cardiol."},{"key":"1085_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/HYPERTENSIONAHA.120.15056","volume":"76","author":"JM Roberts","year":"2020","unstructured":"Roberts, J. M. & Countouris, M. White coat hypertension in pregnancy: the challenge of combining inconsistent data. Hypertension\u00a076, 35\u201337 (2020).","journal-title":"Hypertension"},{"key":"1085_CR27","doi-asserted-by":"publisher","first-page":"e212","DOI":"10.1161\/HYP.0000000000000257","volume":"82","author":"DW Jones","year":"2025","unstructured":"Jones, D. W. et al. AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Hypertension 82, e212\u2013e316 (2025).","journal-title":"Hypertension"},{"key":"1085_CR28","doi-asserted-by":"publisher","first-page":"582","DOI":"10.5694\/mja2.52312","volume":"220","author":"R Shanmugalingam","year":"2024","unstructured":"Shanmugalingam, R. et al. A summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) hypertension in pregnancy guideline. Med. J. Aust. 220, 582\u2013591 (2024).","journal-title":"Med. J. Aust."},{"key":"1085_CR29","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1161\/HYPERTENSIONAHA.124.22731","volume":"8","author":"S Leonard","year":"2024","unstructured":"Leonard, S. et al. Chronic hypertension during pregnancy: prevalence and treatment in the United States, 2008\u20132021. Hypertension\u00a08, 1716\u20131723 (2024).","journal-title":"Hypertension"},{"key":"1085_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-015-0563-z","volume":"17","author":"L Malha","year":"2015","unstructured":"Malha, L. & August, P. Secondary hypertension in pregnancy. Curr. Hypertens. Rep. 17, 53 (2015).","journal-title":"Curr. Hypertens. Rep."},{"key":"1085_CR31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1161\/HYPERTENSIONAHA.109.129882","volume":"54","author":"G Mancia","year":"2009","unstructured":"Mancia, G. et al. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension\u00a054, 226\u2013232 (2009).","journal-title":"Hypertension"},{"key":"1085_CR32","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s00404-023-07247-7","volume":"309","author":"S Hadizadeh","year":"2024","unstructured":"Hadizadeh, S. et al. Development of preeclampsia in pregnant women with white-coat hypertension: a systematic review and meta-analysis. Arch. Gynecol. Obstet. 309, 929\u2013937 (2024).","journal-title":"Arch. Gynecol. Obstet."},{"key":"1085_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41371-021-00649-7","volume":"37","author":"MR Salazar","year":"2023","unstructured":"Salazar, M. R. et al. Masked hypertension and neonatal outcome in high-risk pregnancies. J. Hum. Hypertens. 37, 36\u201341 (2023).","journal-title":"J. Hum. Hypertens."},{"key":"1085_CR34","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/S0002-9378(98)70501-0","volume":"178","author":"MA Brown","year":"1998","unstructured":"Brown, M. A. et al. Ambulatory blood pressure monitoring in pregnancy: what is normal? Am. J. Obstet. Gynecol. 178, 836\u2013842 (1998).","journal-title":"J. Obstet. Gynecol."},{"key":"1085_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13081457","volume":"13","author":"WG Espeche","year":"2023","unstructured":"Espeche, W. G. & Salazar, M. R. Ambulatory blood pressure monitoring for diagnosis and management of hypertension in pregnant women. Diagnostics 13, 1457 (2023).","journal-title":"Diagnostics"},{"key":"1085_CR36","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.preghy.2018.04.002","volume":"12","author":"S Pears","year":"2018","unstructured":"Pears, S., Makris, A. & Hennessy, A. The chronobiology of blood pressure in pregnancy. Pregnancy Hypertens. 12, 104\u2013109 (2018).","journal-title":"Pregnancy Hypertens."},{"key":"1085_CR37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/uog.21867","volume":"55","author":"N Khan","year":"2020","unstructured":"Khan, N. et al. Impact of new definitions of pre-eclampsia on incidence and performance of first-trimester screening. Ultrasound Obstet. Gynecol. 55, 50\u201357 (2020).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"1085_CR38","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0140-6736(23)02357-7","volume":"403","author":"A Hurrell","year":"2024","unstructured":"Hurrell, A. et al. Repeat placental growth factor-based testing in women with suspected preterm pre-eclampsia (PARROT-2): a multicentre, parallel-group, superiority, randomised controlled trial. Lancet\u00a0403, 619\u2013631 (2024).","journal-title":"Lancet"},{"key":"1085_CR39","doi-asserted-by":"publisher","first-page":"S1211","DOI":"10.1016\/j.ajog.2020.10.027","volume":"226","author":"A Hauspurg","year":"2020","unstructured":"Hauspurg, A. & Jeyabalan, A. Postpartum pre-eclampsia or eclampsia: defining its place and management among the hypertensive disorders of pregnancy. Am. J. Obstet. Gynecol. 226, S1211\u2013S1221 (2020).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1085_CR40","doi-asserted-by":"publisher","first-page":"616.e1","DOI":"10.1016\/j.ajog.2018.02.016","volume":"218","author":"NR Blue","year":"2018","unstructured":"Blue, N. R. et al. Effect of ibuprofen vs acetaminophen on postpartum hypertension in pre-eclampsia with severe features: a double-masked, randomized controlled trial. Am. J. Obstet. Gynecol. 218, 616.e1\u2013616.e8 (2018).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1085_CR41","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","volume":"161","author":"JM Roberts","year":"1989","unstructured":"Roberts, J. M. et al. Pre-eclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol. 161, 1200\u20131204 (1989).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1085_CR42","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/0002-9378(84)90468-X","volume":"150","author":"TM Stubbs","year":"1984","unstructured":"Stubbs, T. M., Lazarchick, J. & Horger, E. O. 3rd. Plasma fibronectin levels in pre-eclampsia: a possible biochemical marker for vascular endothelial damage. Am. J. Obstet. Gynecol. 150, 885\u2013887 (1984).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1085_CR43","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1681\/ASN.2007020255","volume":"18","author":"IE Stillman","year":"2007","unstructured":"Stillman, I. E. & Karumanchi, S. A. The glomerular injury of pre-eclampsia. J. Am. Soc. Nephrol. 18, 2281\u20132284 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1085_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semnephrol.2010.10.002","volume":"31","author":"T Cornelis","year":"2011","unstructured":"Cornelis, T., Odutayo, Keunen, J. & Hladunewich, M. The kidney in normal pregnancy and pre-eclampsia. Semin. Nephrol. 31, 4\u201314 (2011).","journal-title":"Semin. Nephrol."},{"key":"1085_CR45","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jtha.2023.10.022","volume":"22","author":"L Neave","year":"2024","unstructured":"Neave, L. et al. Alterations in the von Willebrand factor\/ADAMTS-13 axis in pre-eclampsia. J. Thromb. Haemost. 22, 455\u2013465 (2024).","journal-title":"J. Thromb. Haemost."},{"key":"1085_CR46","first-page":"383","volume":"110","author":"L Bowyer","year":"2003","unstructured":"Bowyer, L., Brown, M. A. & Jones, M. Forearm blood flow in pre-eclampsia. BJOG 110, 383\u2013391 (2003).","journal-title":"BJOG"},{"key":"1085_CR47","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1182\/asheducation-2015.1.644","volume":"2015","author":"JN George","year":"2015","unstructured":"George, J. N., Nester, C. M. & McIntosh, J. J. Syndromes of thrombotic microangiopathy associated with pregnancy. Hematology Am. Soc. Hematol. Educ. Program 2015, 644\u2013648 (2015).","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"1085_CR48","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1161\/HYPERTENSIONAHA.113.01115","volume":"61","author":"IM Craici","year":"2013","unstructured":"Craici, I. M. et al. Podocyturia predates proteinuria and clinical features of pre-eclampsia: longitudinal prospective study. Hypertension\u00a061, 1289\u20131296 (2013).","journal-title":"Hypertension"},{"key":"1085_CR49","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.biopha.2018.10.082","volume":"109","author":"H Moghaddas Sani","year":"2019","unstructured":"Moghaddas Sani, H., Zununi Vahed, S. & Ardalan, M. Pre-eclampsia: a close look at renal dysfunction. Biomed. Pharmacother. 109, 408\u2013416 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"1085_CR50","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/HYPERTENSIONAHA.111.176602","volume":"58","author":"N Mishra","year":"2011","unstructured":"Mishra, N., Nugent, W. H., Mahavadi, S. & Walsh, S. W. Mechanisms of enhanced vascular reactivity in pre-eclampsia. Hypertension\u00a058, 867\u2013873 (2011).","journal-title":"Hypertension"},{"key":"1085_CR51","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.devcel.2021.04.001","volume":"56","author":"B Zhang","year":"2021","unstructured":"Zhang, B. et al. Human placental cytotrophoblast epigenome dynamics over gestation and alterations in placental disease. Dev. Cell 56, 1238\u20131252.e5 (2021).","journal-title":"Dev. Cell"},{"key":"1085_CR52","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/ajh.2011.99","volume":"24","author":"EM George","year":"2011","unstructured":"George, E. M. & Granger, J. P. Endothelin: key mediator of hypertension in pre-eclampsia. Am. J. Hypertens. 24, 964\u2013969 (2011).","journal-title":"Am. J. Hypertens."},{"key":"1085_CR53","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1161\/HYPERTENSIONAHA.117.09386","volume":"70","author":"AE Stanhewicz","year":"2017","unstructured":"Stanhewicz, A. E., Jandu, S., Santhanam, L. & Alexander, L. M. Increased angiotensin II sensitivity contributes to microvascular dysfunction in women who have had pre-eclampsia. Hypertension\u00a070, 382\u2013389 (2017).","journal-title":"Hypertension"},{"key":"1085_CR54","first-page":"262","volume":"25","author":"H Nisell","year":"1988","unstructured":"Nisell, H., Martinsson, A. & Hjemdahl, P. Reduced \u03b22-adrenoceptor sensitivity in normal pregnancy but not in pregnancy-induced hypertension. Gynecol. Obstet. Invest. 25, 262\u2013267 (1988).","journal-title":"Gynecol. Obstet. Invest."},{"key":"1085_CR55","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0095-5108(18)30493-7","volume":"18","author":"BM Sibai","year":"1991","unstructured":"Sibai, B. M. & Mabie, W. C. Hemodynamics of pre-eclampsia. Clin. Perinatol. 18, 727\u2013747 (1991).","journal-title":"Clin. Perinatol."},{"key":"1085_CR56","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/1471-0528.16678","volume":"129","author":"EG Mulder","year":"2022","unstructured":"Mulder, E. G. et al. Cardiac output and peripheral vascular resistance during normotensive and hypertensive pregnancy \u2014 a systematic review and meta-analysis. BJOG\u00a0129, 696\u2013707 (2022).","journal-title":"BJOG"},{"key":"1085_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2024.100980","volume":"3","author":"LJ Shaw","year":"2024","unstructured":"Shaw, L. J. et al. Pathophysiology of pre-eclampsia-induced vascular dysfunction and implications for subclinical myocardial damage and heart failure. JACC Adv. 3, 100980 (2024).","journal-title":"JACC Adv."},{"key":"1085_CR58","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/GCO.0000000000000419","volume":"29","author":"E Kalafat","year":"2017","unstructured":"Kalafat, E. & Thilaganathan, B. Cardiovascular origins of pre-eclampsia. Curr. Opin. Obstet. Gynecol. 29, 383\u2013389 (2017).","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"1085_CR59","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1042\/CS20160108","volume":"130","author":"OC Logue","year":"2016","unstructured":"Logue, O. C., George, E. M. & Bidwell, G. L. 3rd. Pre-eclampsia and the brain: neural control of cardiovascular changes during pregnancy and neurological outcomes of pre-eclampsia. Clin. Sci. 130, 1417\u20131434 (2016).","journal-title":"Clin. Sci."},{"key":"1085_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00563","volume":"10","author":"ER Lumbers","year":"2019","unstructured":"Lumbers, E. R., Delforce, S. J., Arthurs, A. L. & Pringle, K. G. Causes and consequences of the dysregulated maternal renin-angiotensin system in pre-eclampsia. Front. Endocrinol. 10, 563 (2019).","journal-title":"Front. Endocrinol."},{"key":"1085_CR61","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ejogrb.2022.05.033","volume":"274","author":"P Tam\u00e1s","year":"2022","unstructured":"Tam\u00e1s, P. et al. Pre-eclampsia subtypes: clinical aspects regarding pathogenesis, signs, and management with special attention to diuretic administration. Eur. J. Obstet. Gynecol. Reprod. Biol. 274, 175\u2013181 (2022).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"1085_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.896811","volume":"9","author":"AC Godtfredsen","year":"2022","unstructured":"Godtfredsen, A. C. et al. Depressed kallikrein generation in women with pre-eclampsia: a matched cross-sectional study. Front. Med. 9, 896811 (2022).","journal-title":"Front. Med."},{"key":"1085_CR63","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1161\/HYPERTENSIONAHA.113.01983","volume":"62","author":"DS Genest","year":"2013","unstructured":"Genest, D. S. et al. Novel role of the renin-angiotensin system in pre-eclampsia superimposed on chronic hypertension and the effects of exercise in a mouse model. Hypertension\u00a062, 1055\u20131061 (2013).","journal-title":"Hypertension"},{"key":"1085_CR64","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1007\/s43032-023-01182-3","volume":"30","author":"CA West","year":"2023","unstructured":"West, C. A. Late pregnant Dahl salt-sensitive rats from Charles River laboratories do not exhibit superimposed pre-eclampsia. Reprod. Sci. 30, 2580\u20132583 (2023).","journal-title":"Reprod. Sci."},{"key":"1085_CR65","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/19396368.2021.1981486","volume":"68","author":"S Ramdin","year":"2022","unstructured":"Ramdin, S. et al. Physiological characterization of an arginine vasopressin rat model of pre-eclampsia. Syst. Biol. Reprod. Med. 68, 55\u201369 (2022).","journal-title":"Syst. Biol. Reprod. Med."},{"key":"1085_CR66","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/ATVBAHA.123.320474","volume":"44","author":"LA Biwer","year":"2024","unstructured":"Biwer, L. A. et al. Prior exposure to experimental pre-eclampsia increases atherosclerotic plaque inflammation in atherogenic mice\u2014brief report. Arterioscler. Thromb. Vasc. Biol. 44, 946\u2013953 (2024).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1085_CR67","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1161\/CIRCRESAHA.122.321228","volume":"132","author":"LA Biwer","year":"2023","unstructured":"Biwer, L. A. et al. Smooth muscle mineralocorticoid receptor promotes hypertension after pre-eclampsia. Circ. Res. 132, 674\u2013689 (2023).","journal-title":"Circ. Res."},{"key":"1085_CR68","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1161\/HYPERTENSIONAHA.114.04971","volume":"65","author":"D Pruthi","year":"2015","unstructured":"Pruthi, D. et al. Exposure to experimental pre-eclampsia in mice enhances the vascular response to future injury. Hypertension\u00a065, 863\u2013870 (2015).","journal-title":"Hypertension"},{"key":"1085_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/pin.13186","volume":"72","author":"JE Birkness-Gartman","year":"2022","unstructured":"Birkness-Gartman, J. E. & Oshima, K. Liver pathology in pregnancy. Pathol. Int. 72, 1\u201313 (2022).","journal-title":"Pathol. Int."},{"key":"1085_CR70","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/14767058.2019.1572737","volume":"34","author":"MO Alese","year":"2021","unstructured":"Alese, M. O., Moodley, J. & Naicker, T. Pre-eclampsia and HELLP syndrome, the role of the liver. J. Matern. Fetal. Neonatal Med. 34, 117\u2013123 (2021).","journal-title":"J. Matern. Fetal. Neonatal Med."},{"key":"1085_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073851","volume":"23","author":"A Gardikioti","year":"2022","unstructured":"Gardikioti, A. et al. Molecular advances in pre-eclampsia and HELLP syndrome. Int. J. Mol. Sci. 23, 3851 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1085_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/cells11050789","volume":"11","author":"T Friis","year":"2022","unstructured":"Friis, T. et al. Cerebral biomarkers and blood-brain barrier integrity in pre-eclampsia. Cells 11, 789 (2022).","journal-title":"Cells"},{"key":"1085_CR73","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1161\/HYPERTENSIONAHA.122.19408","volume":"80","author":"C Escudero","year":"2023","unstructured":"Escudero, C. et al. Brain vascular dysfunction in mothers and their children exposed to pre-eclampsia. Hypertension\u00a080, 242\u2013256 (2023).","journal-title":"Hypertension"},{"key":"1085_CR74","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-015-0575-8","volume":"17","author":"ES Hammer","year":"2015","unstructured":"Hammer, E. S. & Cipolla, M. J. Cerebrovascular dysfunction in pre-eclamptic pregnancies. Curr. Hypertens. Rep. 17, 64 (2015).","journal-title":"Curr. Hypertens. Rep."},{"key":"1085_CR75","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/practneurol-2021-003194","volume":"22","author":"JD Triplett","year":"2021","unstructured":"Triplett, J. D., Kutlubaev, M. A., Kermode, A. G. & Hardy, T. Posterior reversible encephalopathy syndrome (PRES): diagnosis and management. Pract. Neurol. 22, 183\u2013189 (2021).","journal-title":"Pract. Neurol."},{"key":"1085_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-021-04145-1","volume":"21","author":"H Mai","year":"2021","unstructured":"Mai, H. et al. MRI characteristics of brain edema in pre-eclampsia\/eclampsia patients with posterior reversible encephalopathy syndrome. BMC Pregnancy Childbirth 21, 669 (2021).","journal-title":"BMC Pregnancy Childbirth"},{"key":"1085_CR77","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/uog.20105","volume":"53","author":"A Sotiriadis","year":"2019","unstructured":"Sotiriadis, A. et al. ISUOG practice guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia. Ultrasound Obstet. Gynecol. 53, 7\u201322 (2019).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"1085_CR78","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/uog.19112","volume":"52","author":"MY Tan","year":"2018","unstructured":"Tan, M. Y. et al. Screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks\u2019 gestation. Ultrasound Obstet. Gynecol. 52, 186\u2013195 (2018).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"1085_CR79","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/aogs.12919","volume":"95","author":"G Acharya","year":"2016","unstructured":"Acharya, G., Sonesson, S. E., Flo, K., R\u00e4s\u00e4nen, J. & Odibo, A. Hemodynamic aspects of normal human feto-placental (umbilical) circulation. Acta Obstet. Gynecol. Scand. 95, 672\u2013682 (2016).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"1085_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13041111","volume":"13","author":"Y Cohen","year":"2024","unstructured":"Cohen, Y., Gutvirtz, G., Avnon, T. & Sheiner, E. Chronic hypertension in pregnancy and placenta-mediated complications regardless of pre-eclampsia. J. Clin. Med. 13, 1111 (2024).","journal-title":"J. Clin. Med."},{"key":"1085_CR81","doi-asserted-by":"publisher","first-page":"S954","DOI":"10.1016\/j.ajog.2020.10.024","volume":"226","author":"K Melchiorre","year":"2022","unstructured":"Melchiorre, K., Giorgione, V. & Thilaganathan, B. The placenta and pre-eclampsia: villain or victim? Am. J. Obstet. Gynecol. 226, S954\u2013S962 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1085_CR82","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.7863\/jum.2010.29.7.1103","volume":"29","author":"J Espinoza","year":"2010","unstructured":"Espinoza, J. et al. Should bilateral uterine artery notching be used in the risk assessment for pre-eclampsia, small-for-gestational-age, and gestational hypertension? J. Ultrasound Med. 29, 1103\u20131115 (2010).","journal-title":"J. Ultrasound Med."},{"key":"1085_CR83","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/HYPERTENSIONAHA.116.07286","volume":"67","author":"A Makris","year":"2016","unstructured":"Makris, A. et al. Placental growth factor reduces blood pressure in a uteroplacental ischemia model of pre-eclampsia in nonhuman primates. Hypertension 67, 1263\u20131272 (2016).","journal-title":"Hypertension"},{"key":"1085_CR84","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/1440-1681.13169","volume":"47","author":"K Chau","year":"2020","unstructured":"Chau, K. et al. Effect of placental growth factor in models of experimental pre-eclampsia and trophoblast invasion. Clin. Exp. Pharmacol. Physiol. 47, 49\u201359 (2020).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"1085_CR85","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/sj.ki.5002175","volume":"71","author":"A Makris","year":"2007","unstructured":"Makris, A. et al. Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int. 71, 977\u2013984 (2007).","journal-title":"Kidney Int."},{"key":"1085_CR86","doi-asserted-by":"publisher","first-page":"R204","DOI":"10.1152\/ajpregu.1989.257.1.R204","volume":"257","author":"LL Woods","year":"1989","unstructured":"Woods, L. L. & Brooks, V. L. Role of the renin-angiotensin system in hypertension during reduced uteroplacental perfusion pressure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 257, R204\u2013R209 (1989).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"1085_CR87","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-016-0633-x","volume":"18","author":"B LaMarca","year":"2016","unstructured":"LaMarca, B. et al. Placental ischemia and resultant phenotype in animal models of pre-eclampsia. Curr. Hypertens. Rep. 18, 38 (2016).","journal-title":"Curr. Hypertens. Rep."},{"key":"1085_CR88","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0002-9378(77)90296-4","volume":"128","author":"D Cavanagh","year":"1977","unstructured":"Cavanagh, D., Rao, P. S., Tsai, C. C. & O\u2019Connor, T. C. Experimental toxemia in the pregnant primate. Am. J. Obstet. Gynecol. 128, 75\u201385 (1977).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1085_CR89","first-page":"573","volume":"86","author":"MM Abitbol","year":"1977","unstructured":"Abitbol, M. M., Ober, M. B., Gallo, G. R., Driscoll, S. G. & Pirani, C. L. Experimental toxemia of pregnancy in the monkey, with a preliminary report on renin and aldosterone. Am. J. Pathol. 86, 573\u2013590 (1977).","journal-title":"Am. J. Pathol."},{"key":"1085_CR90","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/nbt.4297","volume":"36","author":"AA Turanov","year":"2018","unstructured":"Turanov, A. A. et al. RNAi modulation of placental sFLT1 for the treatment of pre-eclampsia. Nat. Biotechnol. 36, 1164\u20131173 (2018).","journal-title":"Nat. Biotechnol."},{"key":"1085_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13061784","volume":"13","author":"E Satorres-P\u00e9rez","year":"2024","unstructured":"Satorres-P\u00e9rez, E., Mart\u00ednez-Varea, A., Novillo-Del \u00c1lamo, B., Morales-Rosell\u00f3, J. & Diago-Almela, V. The sFlt-1\/PlGF Ratio at 12, 24, and 32 weeks gestation in twin pregnancies as a predictor of placental dysfunction. J. Clin. Med. 13, 1784 (2024).","journal-title":"J. Clin. Med."},{"key":"1085_CR92","doi-asserted-by":"publisher","first-page":"184.e1","DOI":"10.1016\/j.ajog.2009.09.005","volume":"202","author":"D Kanter","year":"2010","unstructured":"Kanter, D. et al. Angiogenic dysfunction in molar pregnancy. Am. J. Obstet. Gynecol. 202, 184.e1\u2013184.e5 (2010).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1085_CR93","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1161\/HYPERTENSIONAHA.120.14781","volume":"77","author":"JM Roberts","year":"2021","unstructured":"Roberts, J. M. et al. Subtypes of pre-eclampsia: recognition and determining clinical usefulness. Hypertension\u00a077, 1430\u20131441 (2021).","journal-title":"Hypertension"},{"key":"1085_CR94","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.placenta.2009.02.009","volume":"30","author":"GJ Burton","year":"2009","unstructured":"Burton, G. J., Woods, A. W., Jauniaux, E. & Kingdom, J. C. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta\u00a030, 473\u2013482 (2009).","journal-title":"Placenta"},{"key":"1085_CR95","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1530\/REP-09-0092","volume":"138","author":"GJ Burton","year":"2009","unstructured":"Burton, G. J., Charnock-Jones, D. S. & Jauniaux, E. Regulation of vascular growth and function in the human placenta. Reproduction\u00a0138, 895\u2013902 (2009).","journal-title":"Reproduction"},{"key":"1085_CR96","doi-asserted-by":"publisher","first-page":"287.e1","DOI":"10.1016\/j.ajog.2016.12.029","volume":"216","author":"CA Labarrere","year":"2017","unstructured":"Labarrere, C. A. et al. Failure of physiologic transformation of spiral arteries, endothelial and trophoblast cell activation, and acute atherosis in the basal plate of the placenta. Am. J. Obstet. Gynecol. 216, 287.e1\u2013287.e16 (2017).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1085_CR97","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1471-0528.1966.tb05175.x","volume":"73","author":"I Brosens","year":"1966","unstructured":"Brosens, I. & Dixon, H. G. The anatomy of the maternal side of the placenta. J. Obstet. Gynaecol. Br. Commonw. 73, 357\u2013363 (1966).","journal-title":"J. Obstet. Gynaecol. Br. Commonw."},{"key":"1085_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.placenta.2024.08.010","volume":"156","author":"L Brouwers","year":"2024","unstructured":"Brouwers, L. et al. Prevalence of placental bed spiral artery pathology in pre-eclampsia and fetal growth restriction: a prospective cohort study. Placenta\u00a0156, 1\u20139 (2024).","journal-title":"Placenta"},{"key":"1085_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/nu15163564","volume":"15","author":"L Lawless","year":"2023","unstructured":"Lawless, L., Qin, Y., Xie, L. & Zhang, K. Trophoblast differentiation: mechanisms and implications for pregnancy complications. Nutrients\u00a015, 3564 (2023).","journal-title":"Nutrients"},{"key":"1085_CR100","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1471-0528.1991.tb13450.x","volume":"98","author":"R Pijnenborg","year":"1991","unstructured":"Pijnenborg, R. et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br. J. Obstet. Gynaecol. 98, 648\u2013655 (1991).","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"1085_CR101","doi-asserted-by":"publisher","first-page":"58.e1","DOI":"10.1016\/j.ajog.2011.07.037","volume":"206","author":"S Verlohren","year":"2012","unstructured":"Verlohren, S. et al. The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in pre-eclamptic patients. Am. J. Obstet. Gynecol. 206, 58.e1\u201358.e8 (2012).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1085_CR102","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1210\/en.2019-00059","volume":"160","author":"JS Babischkin","year":"2019","unstructured":"Babischkin, J. S. et al. Vascular endothelial growth factor delivery to placental basal plate promotes uterine artery remodeling in the primate. Endocrinology 160, 1492\u20131505 (2019).","journal-title":"Endocrinology"},{"key":"1085_CR103","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqac012","volume":"163","author":"GW Aberdeen","year":"2022","unstructured":"Aberdeen, G. W., Babischkin, J. S., Lindner, J. R., Pepe, G. J. & Albrecht, E. D. Placental sFlt-1 gene delivery in early primate pregnancy suppresses uterine spiral artery remodeling. Endocrinology 163, bqac012 (2022).","journal-title":"Endocrinology"},{"key":"1085_CR104","doi-asserted-by":"publisher","first-page":"H1712","DOI":"10.1152\/ajpheart.00613.2020","volume":"320","author":"ED Albrecht","year":"2021","unstructured":"Albrecht, E. D., Babischkin, J. S., Aberdeen, G. W., Burch, M. G. & Pepe, G. J. Maternal systemic vascular dysfunction in a primate model of defective uterine spiral artery remodeling. Am. J. Physiol. Heart Circ. Physiol. 320, H1712\u2013H1723 (2021).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1085_CR105","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1161\/HYPERTENSIONAHA.121.17567","volume":"78","author":"R Vogtmann","year":"2021","unstructured":"Vogtmann, R. et al. Circulating maternal sFLT1 (soluble fms-like tyrosine kinase-1) is sufficient to impair spiral arterial remodeling in a pre-eclampsia mouse model. Hypertension 78, 1067\u20131079 (2021).","journal-title":"Hypertension"},{"key":"1085_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijgo.12802","volume":"145","author":"LC Poon","year":"2019","unstructured":"Poon, L. C. et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int. J. Gynaecol. Obstet. 145, 1\u201333 (2019).","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"1085_CR107","doi-asserted-by":"publisher","first-page":"C1313","DOI":"10.1152\/ajpcell.00035.2008","volume":"294","author":"K Forbes","year":"2008","unstructured":"Forbes, K., Westwood, M., Baker, P. N. & Aplin, J. D. Insulin-like growth factor I and II regulate the life cycle of trophoblast in the developing human placenta. Am. J. Physiol. Cell. Physiol. 294, C1313\u2013C1322 (2008).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"1085_CR108","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58157-y","volume":"16","author":"MA Elovitz","year":"2025","unstructured":"Elovitz, M. A. et al. Molecular subtyping of hypertensive disorders of pregnancy. Nat. Commun. 16, 2948 (2025).","journal-title":"Nat. Commun."},{"key":"1085_CR109","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/pd.1251","volume":"25","author":"K Spencer","year":"2005","unstructured":"Spencer, K., Yu, C. K., Cowans, N. J., Otigbah, C. & Nicolaides, K. H. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free \u03b2-hCG and with second-trimester uterine artery Doppler. Prenat. Diagn. 25, 949\u2013953 (2005).","journal-title":"Prenat. Diagn."},{"key":"1085_CR110","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/B978-0-12-800094-6.00005-4","volume":"63","author":"M Kalousov\u00e1","year":"2014","unstructured":"Kalousov\u00e1, M., Muravsk\u00e1, A. & Zima, T. Pregnancy-associated plasma protein A (PAPP-A) and pre-eclampsia. Adv. Clin. Chem. 63, 169\u2013209 (2014).","journal-title":"Adv. Clin. Chem."},{"key":"1085_CR111","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.placenta.2014.07.006","volume":"35","author":"MT Ratsep","year":"2014","unstructured":"Ratsep, M. T., Carmeliet, P., Adams, M. A. & Croy, B. A. Impact of placental growth factor deficiency on early mouse implant site angiogenesis. Placenta 35, 772\u2013775 (2014).","journal-title":"Placenta"},{"key":"1085_CR112","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/aji.12417","volume":"74","author":"G Bobek","year":"2015","unstructured":"Bobek, G., Surmon, L., Mirabito, K. M., Makris, A. & Hennessy, A. Placental regulation of inflammation and hypoxia after TNF-\u03b1 infusion in mice. Am. J. Reprod. Immunol. 74, 407\u2013418 (2015).","journal-title":"Am. J. Reprod. Immunol."},{"key":"1085_CR113","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cyto.2004.10.011","volume":"29","author":"S Orange","year":"2005","unstructured":"Orange, S. et al. Interleukin-10 regulates arterial pressure in early primate pregnancy. Cytokine 29, 176\u2013185 (2005).","journal-title":"Cytokine"},{"key":"1085_CR114","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s11906-007-0088-1","volume":"9","author":"BD LaMarca","year":"2007","unstructured":"LaMarca, B. D., Ryan, M. J., Gilbert, J. S., Murphy, S. R. & Granger, J. P. Inflammatory cytokines in the pathophysiology of hypertension during pre-eclampsia. Curr. Hypertens. Rep. 9, 480\u2013485 (2007).","journal-title":"Curr. Hypertens. Rep."},{"key":"1085_CR115","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-020-1033-9","volume":"22","author":"V Di Leo","year":"2020","unstructured":"Di Leo, V., Capaccio, F. & Gesualdo, L. Pre-eclampsia and glomerulonephritis: a bidirectional association. Curr. Hypertens. Rep. 22, 36 (2020).","journal-title":"Curr. Hypertens. Rep."},{"key":"1085_CR116","doi-asserted-by":"publisher","first-page":"S907","DOI":"10.1016\/j.ajog.2020.09.047","volume":"226","author":"CWG Redman","year":"2022","unstructured":"Redman, C. W. G., Staff, A. C. & Roberts, J. M. Syncytiotrophoblast stress in pre-eclampsia: the convergence point for multiple pathways. Am. J. Obstet. Gynecol. 226, S907\u2013S927 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1085_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102864","volume":"57","author":"DC Cornelius","year":"2020","unstructured":"Cornelius, D. C. & Wallace, K. Autophagy in pre-eclampsia: a new target? EBioMedicine\u00a057, 102864 (2020).","journal-title":"EBioMedicine"},{"key":"1085_CR118","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1177\/1933719111424445","volume":"19","author":"HJ Kliman","year":"2012","unstructured":"Kliman, H. J. et al. Placental protein 13 and decidual zones of necrosis: an immunologic diversion that may be linked to pre-eclampsia. Reprod. Sci. 19, 16\u201330 (2012).","journal-title":"Reprod. Sci."},{"key":"1085_CR119","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adi0077","volume":"16","author":"JD Roh","year":"2024","unstructured":"Roh, J. D. et al. Placental senescence pathophysiology is shared between peripartum cardiomyopathy and pre-eclampsia in mouse and human. Sci. Transl. Med. 16, eadi0077 (2024).","journal-title":"Sci. Transl. Med."},{"key":"1085_CR120","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M111.012526","volume":"10","author":"B Cox","year":"2011","unstructured":"Cox, B. et al. Translational analysis of mouse and human placental protein and mRNA reveals distinct molecular pathologies in human pre-eclampsia. Mol. Cell. Proteomics. 10, M111.012526 (2011).","journal-title":"Mol. Cell. Proteomics."},{"key":"1085_CR121","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19051496","volume":"19","author":"R Aouache","year":"2018","unstructured":"Aouache, R., Biquard, L., Vaiman, D. & Miralles, F. Oxidative stress in pre-eclampsia and placental diseases. Int. J. Mol. Sci. 19, 1496 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"1085_CR122","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.medj.2023.07.005","volume":"4","author":"I Admat","year":"2023","unstructured":"Admat, I. et al. Two distinct molecular faces of pre-eclampsia revealed by single-cell transcriptomics. Med 4, 687\u2013709.e7 (2023).","journal-title":"Med"},{"key":"1085_CR123","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41581-022-00670-0","volume":"19","author":"E Deer","year":"2023","unstructured":"Deer, E. et al. The role of immune cells and mediators in pre-eclampsia. Nat. Rev. Nephrol. 19, 257\u2013270 (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"1085_CR124","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-017-0757-7","volume":"19","author":"L Amaral","year":"2017","unstructured":"Amaral, L., Wallace, K., Owens, M. & Lamarca, B. Pathophysiology and current clinical management of pre-eclampsia. Curr. Hypertens. Rep. 19, 61 (2017).","journal-title":"Curr. Hypertens. Rep."},{"key":"1085_CR125","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-020-01099-1","volume":"22","author":"A Kattah","year":"2020","unstructured":"Kattah, A. Pre-eclampsia and kidney disease: deciphering cause and effect. Curr. Hypertens. Rep. 22, 91 (2020).","journal-title":"Curr. Hypertens. Rep."},{"key":"1085_CR126","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.avsg.2015.03.037","volume":"29","author":"CJ Vance","year":"2015","unstructured":"Vance, C. J., Taylor, R. N., Craven, T. E., Edwards, M. S. & Corriere, M. A. Increased prevalence of pre-eclampsia among women undergoing procedural intervention for renal artery fibromuscular dysplasia. Ann. Vasc. Surg. 29, 1105\u20131110 (2015).","journal-title":"Ann. Vasc. Surg."},{"key":"1085_CR127","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/hdi.12420","volume":"20","author":"M Hladunewich","year":"2016","unstructured":"Hladunewich, M. & Schatell, D. Intensive dialysis and pregnancy. Hemodial. Int. 20, 339\u2013348 (2016).","journal-title":"Hemodial. Int."},{"key":"1085_CR128","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1093\/ckj\/sfac060","volume":"15","author":"O Cabarcas-Barbosa","year":"2022","unstructured":"Cabarcas-Barbosa, O., Capalbo, O., Ferrero-Fern\u00e1ndez, A. & Musso, C. G. Kidney-placenta crosstalk in health and disease. Clin. Kidney J. 15, 1284\u20131289 (2022).","journal-title":"Clin. Kidney J."},{"key":"1085_CR129","first-page":"205","volume":"10","author":"H Shiiki","year":"1990","unstructured":"Shiiki, H. et al. Focal and segmental glomerulosclerosis in preeclamptic patients with nephrotic syndrome. Am. J. Nephrol. 10, 205\u2013212 (1990).","journal-title":"Am. J. Nephrol."},{"key":"1085_CR130","doi-asserted-by":"publisher","first-page":"S844","DOI":"10.1016\/j.ajog.2021.11.1356","volume":"226","author":"E Jung","year":"2022","unstructured":"Jung, E. et al. The etiology of pre-eclampsia. Am. J. Obstet. Gynecol. 226, S844\u2013S866 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1085_CR131","doi-asserted-by":"publisher","first-page":"S786","DOI":"10.1016\/j.ajog.2021.12.001","volume":"226","author":"O Erez","year":"2022","unstructured":"Erez, O. et al. Pre-eclampsia and eclampsia: the conceptual evolution of a syndrome. Am. J. Obstet. Gynecol. 226, S786\u2013S803 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1085_CR132","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1365-3016.2007.00836.x","volume":"21","author":"ZC Luo","year":"2007","unstructured":"Luo, Z. C. et al. The effects and mechanisms of primiparity on the risk of pre-eclampsia: a systematic review. Paediatr. Perinat. Epidemiol. 21, 36\u201345 (2007).","journal-title":"Paediatr. Perinat. Epidemiol."},{"key":"1085_CR133","doi-asserted-by":"publisher","first-page":"S963","DOI":"10.1016\/j.ajog.2020.10.023","volume":"226","author":"S Yagel","year":"2022","unstructured":"Yagel, S., Cohen, S. M. & Goldman-Wohl, D. An integrated model of pre-eclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array. Am. J. Obstet. Gynecol. 226, S963\u2013S972 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1085_CR134","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81785-5","volume":"11","author":"AM Nuzzo","year":"2021","unstructured":"Nuzzo, A. M. et al. Placental and maternal sFlt1\/PlGF expression in gestational diabetes mellitus. Sci. Rep. 11, 2312 (2021).","journal-title":"Sci. Rep."},{"key":"1085_CR135","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.809528","volume":"10","author":"KZ Freimane","year":"2022","unstructured":"Freimane, K. Z., Kerrigan, L., Eastwood, K. A. & Watson, C. J. Pre-eclampsia biomarkers for women with type 1 diabetes mellitus: a comprehensive review of recent literature. Front. Bioeng. Biotechnol. 10, 809528 (2022).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"1085_CR136","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11892-015-0579-4","volume":"15","author":"TL Weissgerber","year":"2015","unstructured":"Weissgerber, T. L. & Mudd, L. M. Pre-eclampsia and diabetes. Curr. Diab. Rep. 15, 9 (2015).","journal-title":"Curr. Diab. Rep."},{"key":"1085_CR137","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41574-022-00734-y","volume":"18","author":"L Jiang","year":"2022","unstructured":"Jiang, L. et al. A global view of hypertensive disorders and diabetes mellitus during pregnancy. Nat. Rev. Endocrinol. 18, 760\u2013775 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1085_CR138","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1056\/NEJMoa2214956","volume":"388","author":"D Simmons","year":"2023","unstructured":"Simmons, D. et al. Treatment of gestational diabetes mellitus diagnosed early in pregnancy. N. Engl. J. Med. 388, 2132\u20132144 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1085_CR139","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11082298","volume":"11","author":"K Mayer-Pickel","year":"2023","unstructured":"Mayer-Pickel, K., Nanda, M., Gajic, M. & Cervar-Zivkovic, M. Pre-eclampsia and the antiphospholipid syndrome. Biomedicines\u00a011, 2298 (2023).","journal-title":"Biomedicines"},{"key":"1085_CR140","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1177\/09612033211004716","volume":"30","author":"K Bremme","year":"2021","unstructured":"Bremme, K., Honkanen, S., Gunnarsson, I. & Chaireti, R. The presence of lupus nephritis additionally increases the risk of pre-eclampsia among pregnant women with systemic lupus erythematosus. Lupus 30, 1031\u20131038 (2021).","journal-title":"Lupus"},{"key":"1085_CR141","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/ppe.12332","volume":"31","author":"JF Simard","year":"2017","unstructured":"Simard, J. F. et al. Early-onset pre-eclampsia in lupus pregnancy. Paediatr. Perinat. Epidemiol. 31, 29\u201336 (2017).","journal-title":"Paediatr. Perinat. Epidemiol."},{"key":"1085_CR142","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e24","volume":"36","author":"EE Lee","year":"2021","unstructured":"Lee, E. E., Jun, J. K. & Lee, E. B. Management of women with antiphospholipid antibodies or antiphospholipid syndrome during pregnancy. J. Korean Med. Sci. 36, e24 (2021).","journal-title":"J. Korean Med. Sci."},{"key":"1085_CR143","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13761","volume":"90","author":"A Hooper","year":"2023","unstructured":"Hooper, A., Bacal, V. & Bedaiwy, M. A. Does adding hydroxychloroquine to empiric treatment improve the live birth rate in refractory obstetrical antiphospholipid syndrome? A systematic review. Am. J. Reprod. Immunol. 90, e13761 (2023).","journal-title":"Am. J. Reprod. Immunol."},{"key":"1085_CR144","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.9691","volume":"21","author":"RE Bohiltea","year":"2021","unstructured":"Bohiltea, R. E. et al. Inherited thrombophilia is significantly associated with severe pre-eclampsia. Exp. Ther. Med. 21, 261 (2021).","journal-title":"Exp. Ther. Med."},{"key":"1085_CR145","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-1-111","volume":"1","author":"MJ Kupferminc","year":"2003","unstructured":"Kupferminc, M. J. Thrombophilia and pregnancy. Reprod. Biol. Endocrinol. 1, 111 (2003).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"1085_CR146","doi-asserted-by":"publisher","first-page":"151.e1","DOI":"10.1016\/j.ajog.2008.09.023","volume":"200","author":"SR Kahn","year":"2009","unstructured":"Kahn, S. R. et al. Inherited thrombophilia and pre-eclampsia within a multicenter cohort: the Montreal Pre-eclampsia Study. Am. J. Obstet. Gynecol. 200, 151.e1\u2013151.e9 (2009).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1085_CR147","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/AOG.0000000000003554","volume":"135","author":"M Gupta","year":"2020","unstructured":"Gupta, M., Govindappagari, S. & Burwick, R. M. Pregnancy-associated atypical hemolytic uremic syndrome: a systematic review. Obstet. Gynecol. 135, 46\u201358 (2020).","journal-title":"Obstet. Gynecol."},{"key":"1085_CR148","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/uog.22174","volume":"58","author":"RJ Martinez-Portilla","year":"2021","unstructured":"Martinez-Portilla, R. J. et al. Incidence of pre-eclampsia and other perinatal complications among pregnant women with congenital heart disease: systematic review and meta-analysis. Ultrasound Obstet. Gynecol. 58, 519\u2013528 (2021).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"1085_CR149","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard, S. E. et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in pre-eclampsia. J. Clin. Invest. 111, 649\u2013658 (2003).","journal-title":"J. Clin. Invest."},{"key":"1085_CR150","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1161\/HYPERTENSIONAHA.109.134668","volume":"54","author":"H Suzuki","year":"2009","unstructured":"Suzuki, H. et al. Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice. Hypertension\u00a054, 1129\u20131135 (2009).","journal-title":"Hypertension"},{"key":"1085_CR151","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine, R. J. et al. Circulating angiogenic factors and the risk of pre-eclampsia. N. Engl. J. Med. 350, 672\u2013683 (2004).","journal-title":"N. Engl. J. Med."},{"key":"1085_CR152","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000341264","volume":"33","author":"R Akolekar","year":"2013","unstructured":"Akolekar, R., Syngelaki, A., Poon, L., Wright, D. & Nicolaides, K. H. Competing risks model in early screening for pre-eclampsia by biophysical and biochemical markers. Fetal Diagn. Ther. 33, 8\u201315 (2013).","journal-title":"Fetal Diagn. Ther."},{"key":"1085_CR153","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.preghy.2020.04.014","volume":"21","author":"JA Hern\u00e1ndez-Pacheco","year":"2020","unstructured":"Hern\u00e1ndez-Pacheco, J. A. et al. The sFlt-1\/PlGF ratio as a triage tool to identify superimposed preeclampsia in women with chronic hypertension in emergency rooms. Pregnancy Hypertens. 21, 38\u201342 (2020).","journal-title":"Pregnancy Hypertens."},{"key":"1085_CR154","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1161\/HYPERTENSIONAHA.124.23411","volume":"81","author":"N Melamed","year":"2024","unstructured":"Melamed, N. et al. Predictive and diagnostic value of the angiogenic proteins in patients with chronic kidney disease. Hypertension\u00a081, 2251\u20132262 (2024).","journal-title":"Hypertension"},{"key":"1085_CR155","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1161\/HYPERTENSIONAHA.120.15146","volume":"77","author":"LA Dr\u00f6ge","year":"2021","unstructured":"Dr\u00f6ge, L. A. Prediction of pre-eclampsia-related adverse outcomes with the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor)-ratio in the clinical routine: a real-world study. Hypertension\u00a077, 461\u2013471 (2021).","journal-title":"Hypertension"},{"key":"1085_CR156","doi-asserted-by":"publisher","first-page":"385.e1","DOI":"10.1016\/j.ajog.2024.07.015","volume":"232","author":"LP Burns","year":"2025","unstructured":"Burns, L. P. et al. Real-world evidence for the utility of serum soluble fms-like tyrosine kinase 1\/placental growth factor test for routine clinical evaluation of hospitalized women with hypertensive disorders of pregnancy. Am. J. Obstet. Gynecol. 232, 385.e1\u2013385.e21 (2025).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1085_CR157","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263443","volume":"17","author":"A Dathan-Stumpf","year":"2022","unstructured":"Dathan-Stumpf, A., Rieger, A., Verlohren, S., Wolf, C. & Stepan, H. sFlt-1\/PlGF ratio for prediction of pre-eclampsia in clinical routine: a pragmatic real-world analysis of healthcare resource utilisation. PLoS ONE 17, e0263443 (2022).","journal-title":"PLoS ONE"},{"key":"1085_CR158","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/ki.2012.348","volume":"83","author":"A Rolfo","year":"2013","unstructured":"Rolfo, A. et al. Chronic kidney disease may be differentially diagnosed from pre-eclampsia by serum biomarkers. Kidney Int. 83, 177\u2013181 (2013).","journal-title":"Kidney Int."},{"key":"1085_CR159","doi-asserted-by":"publisher","first-page":"108.e1","DOI":"10.1016\/j.ajog.2015.09.066","volume":"214","author":"MY Kim","year":"2016","unstructured":"Kim, M. Y. et al. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study. Am. J. Obstet. Gynecol. 214, 108.e1\u2013108.e14 (2016).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1085_CR160","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/uog.19039","volume":"51","author":"MY Tan","year":"2018","unstructured":"Tan, M. Y. et al. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPRE-E. Ultrasound Obstet. Gynecol. 51, 743\u2013750 (2018).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"1085_CR161","volume":"5","author":"A Heazell","year":"2019","unstructured":"Heazell, A. et al. Biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small-for-gestational-age infants. Cochrane Database Syst. Rev. 5, CD012245 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1085_CR162","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00281-017-0645-x","volume":"40","author":"G Girardi","year":"2018","unstructured":"Girardi, G. Complement activation, a threat to pregnancy. Semin. Immunopathol. 40, 103\u2013111 (2018).","journal-title":"Semin. Immunopathol."},{"key":"1085_CR163","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1055\/s-2001-14068","volume":"27","author":"M Sugimura","year":"2001","unstructured":"Sugimura, M., Ohashi, R., Kobayashi, T. & Kanayama, N. Intraplacental coagulation in intrauterine growth restriction: cause or result? Semin. Thromb. Hemost. 27, 107\u2013113 (2001).","journal-title":"Semin. Thromb. Hemost."},{"key":"1085_CR164","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1096\/fasebj.12.2.189","volume":"12","author":"DL Rivera","year":"1998","unstructured":"Rivera, D. L. et al. Interleukin-10 attenuates experimental fetal growth restriction and demise. FASEB J. 12, 189\u2013197 (1998).","journal-title":"FASEB J."},{"key":"1085_CR165","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1530\/RAF-21-0020","volume":"2","author":"SR Ladyman","year":"2021","unstructured":"Ladyman, S. R., Larsen, C. M., Taylor, R. S., Grattan, D. R. & McCowan, L. M. E. Case-control study of prolactin and placental lactogen in SGA pregnancies. Reprod. Fertil. 2, 244\u2013250 (2021).","journal-title":"Reprod. Fertil."},{"key":"1085_CR166","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/j.1471-0528.1984.tb15079.x","volume":"91","author":"BC Obiekw","year":"1984","unstructured":"Obiekw, B. C., Sturdee, D., Cockrill, B. L. & Chard, T. Human placental lactogen in pre-eclampsia. Br. J. Obstet. Gynaecol. 91, 1077\u20131080 (1984).","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"1085_CR167","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/nyas.14733","volume":"1510","author":"F Gomes","year":"2022","unstructured":"Gomes, F. et al. Calcium supplementation for the prevention of hypertensive disorders of pregnancy: current evidence and programmatic considerations. Ann. N. Y. Acad. Sci. 1510, 52\u201367 (2022).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1085_CR168","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1056\/NEJM198703193161204","volume":"316","author":"PA Taufield","year":"1987","unstructured":"Taufield, P. A. et al. Hypocalciuria in pre-eclampsia. N. Engl. J. Med. 316, 715\u2013718 (1987).","journal-title":"N. Engl. J. Med."},{"key":"1085_CR169","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fimmu.2017.00261","volume":"8","author":"AP Cadavid","year":"2017","unstructured":"Cadavid, A. P. Aspirin: the mechanism of action revisited in the context of pregnancy complications. Front. Immunol. 8, 261 (2017).","journal-title":"Front. Immunol."},{"key":"1085_CR170","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jri.2017.10.044","volume":"124","author":"B Xu","year":"2017","unstructured":"Xu, B. et al. The effect of acetyl salicylic acid (aspirin) on trophoblast-endothelial interaction in vitro. J. Reprod. Immunol. 124, 54\u201361 (2017).","journal-title":"J. Reprod. Immunol."},{"key":"1085_CR171","unstructured":"National Institute for Health and Care Excellence (NICE). Hypertension in pregnancy: diagnosis and management. https:\/\/www.nice.org.uk\/guidance\/ng133 (2023)."},{"key":"1085_CR172","first-page":"575","volume":"101","author":"S Rasmussen","year":"2003","unstructured":"Rasmussen, S. & Irgens, L. M. Fetal growth and body proportion in pre-eclampsia. Obstet. Gynecol. 101, 575\u2013583 (2003).","journal-title":"Obstet. Gynecol."},{"key":"1085_CR173","doi-asserted-by":"publisher","first-page":"425.e1","DOI":"10.1016\/j.ajog.2010.12.030","volume":"204","author":"CE Powe","year":"2011","unstructured":"Powe, C. E. et al. Pre-eclampsia and the risk of large-for-gestational-age infants. Am. J. Obstet. Gynecol. 204, 425.e1\u2013425.e6 (2011).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1085_CR174","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1182\/bloodadvances.2019000074","volume":"3","author":"L Thurn","year":"2019","unstructured":"Thurn, L., Wikman, A., Westgren, M. & Lindqvist, P. G. Incidence and risk factors of transfusion reactions in postpartum blood transfusions. Blood Adv. 3, 2298\u20132306 (2019).","journal-title":"Blood Adv."},{"key":"1085_CR175","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/ijgo.14779","volume":"162","author":"HCQQ Okoye","year":"2023","unstructured":"Okoye, H. C. Q. Q. et al. Evaluating the hemostatic effects of tranexamic acid in women with pre-eclampsia. Int. J. Gynaecol. Obstet. 162, 931\u2013936 (2023).","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"1085_CR176","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1161\/HYPERTENSIONAHA.114.03173","volume":"63","author":"UA Nayeri","year":"2014","unstructured":"Nayeri, U. A. et al. Antenatal corticosteroids impact the inflammatory rather than the antiangiogenic profile of women with pre-eclampsia. Hypertension\u00a063, 1285\u20131292 (2014).","journal-title":"Hypertension"},{"key":"1085_CR177","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1097\/HJH.0000000000003747","volume":"42","author":"M Adomi","year":"2024","unstructured":"Adomi, M., McElrath, T. F., Hern\u00e1ndez-D\u00edaz, S., Vine, S. M. & Huybrechts, K. F. TNF-\u03b1 inhibitor use during pregnancy and the risk of pre-eclampsia: population-based cohort study. J. Hypertens. 42, 1529\u20131537 (2024).","journal-title":"J. Hypertens."},{"key":"1085_CR178","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1055\/s-0036-1594017","volume":"34","author":"N Soliman","year":"2017","unstructured":"Soliman, N., Chaput, K., Alshaikh, B. & Yusuf, K. Pre-eclampsia and the risk of bronchopulmonary dysplasia in preterm infants less than 32 weeks\u2019 gestation. Am. J. Perinatol. 34, 585\u2013592 (2017).","journal-title":"Am. J. Perinatol."},{"key":"1085_CR179","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-082880","volume":"14","author":"CA Cluver","year":"2024","unstructured":"Cluver, C. A. et al. Does metformin prolong pregnancy in preterm pre-eclampsia? A study protocol for a South African, hospital-based double-blind, randomised, placebo-controlled trial. BMJ Open\u00a014, e082880 (2024).","journal-title":"BMJ Open"},{"key":"1085_CR180","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1542\/peds.102.4.893","volume":"102","author":"DK Richardson","year":"1998","unstructured":"Richardson, D. K. et al. Declining severity adjusted mortality: evidence of improving neonatal intensive care. Pediatrics\u00a0102, 893\u2013899 (1998).","journal-title":"Pediatrics"},{"key":"1085_CR181","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1681\/ASN.2015020157","volume":"27","author":"R Thadhani","year":"2016","unstructured":"Thadhani, R. et al. Removal of soluble fms-like tyrosine kinase-1 by dextran sulfate apheresis in pre-eclampsia. J. Am. Soc. Nephrol. 27, 903\u2013913 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1085_CR182","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1093\/ndt\/gfy328","volume":"34","author":"N Simon-Tillaux","year":"2019","unstructured":"Simon-Tillaux, N., Lecarpentier, E., Tsatsaris, V. & Hertig, A. Sildenafil for the treatment of pre-eclampsia, an update: should we still be enthusiastic? Nephrol. Dial. Transplant. 34, 1819\u20131826 (2019).","journal-title":"Nephrol. Dial. Transplant."},{"key":"1085_CR183","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1136\/bmj.327.7421.955","volume":"327","author":"LA Magee","year":"2003","unstructured":"Magee, L. A., Cham, C., Waterman, E. J., Ohlsson, A. & von Dadelszen, P. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ 327, 955\u2013960 (2003).","journal-title":"BMJ"},{"key":"1085_CR184","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S2352-4642(17)30176-1","volume":"2","author":"GCS Smith","year":"2018","unstructured":"Smith, G. C. S. The STRIDER trial: one step forward, one step back. Lancet Child. Adolesc. Health\u00a02, 80\u201381 (2018).","journal-title":"Lancet Child. Adolesc. Health"},{"key":"1085_CR185","doi-asserted-by":"publisher","first-page":"S1157","DOI":"10.1016\/j.ajog.2020.09.014","volume":"226","author":"S Tong","year":"2022","unstructured":"Tong, S. et al. Pravastatin, proton-pump inhibitors, metformin, micronutrients, and biologics: new horizons for the prevention or treatment of pre-eclampsia. Am. J. Obstet. Gynecol. 226, S1157\u2013S1170 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1085_CR186","first-page":"1","volume":"38","author":"A Premkumar","year":"2021","unstructured":"Premkumar, A., Ayala, N. K., Miller, C. H., Grobman, W. A. & Miller, E. S. Postpartum NSAID use and adverse outcomes among women with hypertensive disorders of pregnancy: a systematic review and meta-analysis. Am. J. Perinatol. 38, 1\u20139 (2021).","journal-title":"Am. J. Perinatol."},{"key":"1085_CR187","unstructured":"World Health Organization. New recommendations from WHO to help improve the health of preterm birth. https:\/\/www.who.int\/news\/item\/30-09-2022-new-recommendations-from-WHO-to-help-improve-the-health-of-preterm-birth (2022)."},{"key":"1085_CR188","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-002964","volume":"3","author":"J Tooher","year":"2013","unstructured":"Tooher, J. et al. High blood pressure during pregnancy is associated with future cardiovascular disease: an observational cohort study. BMJ Open\u00a03, e002964 (2013).","journal-title":"BMJ Open"},{"key":"1085_CR189","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.385301.BE","volume":"335","author":"L Bellamy","year":"2007","unstructured":"Bellamy, L., Casas, J. P., Hingorani, A. D. & Williams, D. J. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335, 974 (2007).","journal-title":"BMJ"},{"key":"1085_CR190","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1056\/NEJMoa0706790","volume":"359","author":"BE Vikse","year":"2008","unstructured":"Vikse, B. E., Irgens, L. M., Leivestad, T., Skjaerven, R. & Iversen, B. M. Pre-eclampsia and the risk of end-stage renal disease. N. Engl. J. Med. 359, 800\u2013809 (2008).","journal-title":"N. Engl. J. Med."},{"key":"1085_CR191","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1161\/HYPERTENSIONAHA.123.21890","volume":"81","author":"A Henry","year":"2024","unstructured":"Henry, A. Pre-eclampsia-associated cardiovascular risk factors 6 months and 2 years after pregnancy: the p4 study. Hypertension 81, 851\u2013860 (2024).","journal-title":"Hypertension"},{"key":"1085_CR192","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00655","volume":"11","author":"CJ McElwain","year":"2020","unstructured":"McElwain, C. J., Tuboly, E., McCarthy, F. P. & McCarthy, C. M. Mechanisms of endothelial dysfunction in pre-eclampsia and gestational diabetes mellitus: windows into future cardiometabolic health? Front. Endocrinol. 11, 655 (2020).","journal-title":"Front. Endocrinol."},{"key":"1085_CR193","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1161\/HYPERTENSIONAHA.118.11161","volume":"72","author":"JS Tangren","year":"2018","unstructured":"Tangren, J. S. et al. Risk of pre-eclampsia and pregnancy complications in women with a history of acute kidney injury. Hypertension\u00a072, 451\u2013459 (2018).","journal-title":"Hypertension"},{"key":"1085_CR194","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018526","volume":"10","author":"VA deMartelly","year":"2021","unstructured":"deMartelly, V. A. et al. Long-term postpartum cardiac function and its association with pre-eclampsia. J. Am. Heart. Assoc. 10, e018526 (2021).","journal-title":"J. Am. Heart. Assoc."},{"key":"1085_CR195","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l1516","volume":"365","author":"JH Kristensen","year":"2019","unstructured":"Kristensen, J. H., Basit, S., Wohlfahrt, J., Damholt, M. B. & Boyd, H. A. Pre-eclampsia and risk of later kidney disease: nationwide cohort study. BMJ 365, l1516 (2019).","journal-title":"BMJ"},{"key":"1085_CR196","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/S0140-6736(05)66419-7","volume":"365","author":"MR Skilton","year":"2005","unstructured":"Skilton, M. R., Evans, N., Griffiths, K. A., Harmer, J. A. & Celermajer, D. S. Aortic wall thickness in newborns with intrauterine growth restriction. Lancet 365, 1484\u20131486 (2005).","journal-title":"Lancet"},{"key":"1085_CR197","doi-asserted-by":"publisher","DOI":"10.3390\/children10050826","volume":"10","author":"S Koulouraki","year":"2023","unstructured":"Koulouraki, S. et al. Short- and long-term outcomes of pre-eclampsia in offspring: review of the literature. Children 10, 826 (2023).","journal-title":"Children"},{"key":"1085_CR198","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008136","volume":"5","author":"EF Davis","year":"2015","unstructured":"Davis, E. F. et al. Clinical cardiovascular risk during young adulthood in offspring of hypertensive pregnancies: insights from a 20-year prospective follow-up birth cohort. BMJ Open\u00a05, e008136 (2015).","journal-title":"BMJ Open"},{"key":"1085_CR199","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/1440-1681.13008","volume":"45","author":"KR Yeung","year":"2018","unstructured":"Yeung, K. R. et al. Increased salt sensitivity in offspring of pregnancies complicated by experimental pre-eclampsia. Clin. Exp. Pharmacol. Physiol. 45, 1302\u20131308 (2018).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"1085_CR200","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.kint.2025.04.017","volume":"108","author":"I Lihme","year":"2025","unstructured":"Lihme, I. et al. A nationwide register-based cohort study examined the association between pre-eclampsia in mothers and the risk of kidney disease in their offspring. Kidney Int. 108, 283\u2013292 (2025).","journal-title":"Kidney Int."},{"key":"1085_CR201","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1016\/S0140-6736(21)00684-X","volume":"397","author":"B Vogel","year":"2021","unstructured":"Vogel, B. et al. The Lancet Women and Cardiovascular Disease Commission: reducing the global burden by 2030. Lancet 397, 2385\u20132438 (2021).","journal-title":"Lancet"}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01085-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01085-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01085-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:02:58Z","timestamp":1786968178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01085-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":201,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1085"],"URL":"https:\/\/doi.org\/10.1038\/s41581-026-01085-x","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"28 April 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}